FNA
FNA, or FNA Pharma Consulting, is a prominent player in the pharmaceutical consulting industry, headquartered in the United States. Founded in 2010, the company has established itself as a trusted partner for pharmaceutical and biotechnology firms, offering expert guidance in regulatory affairs, clinical development, and market access strategies. With a strong operational presence across North America and Europe, FNA is renowned for its tailored solutions that address the unique challenges faced by its clients. The firm’s core services include regulatory submissions, clinical trial management, and strategic market positioning, all designed to enhance product development and commercial success. FNA's commitment to excellence has earned it a solid reputation, making it a go-to resource for companies seeking to navigate the complexities of the pharmaceutical landscape.
DitchCarbon Score
How does FNA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
FNA's score of 25 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
FNA's reported carbon emissions
In 2023, FNA reported total carbon emissions of approximately 4,487,000 kg CO2e. This figure includes 588,000 kg CO2e from Scope 1 emissions and 3,899,000 kg CO2e from Scope 2 emissions. Compared to 2022, when total emissions were about 5,912,000 kg CO2e, this represents a significant reduction of approximately 1,425,000 kg CO2e. FNA's emissions data for 2021 and 2020 show total emissions of about 4,675,000 kg CO2e and 4,878,000 kg CO2e, respectively, indicating a positive trend in reducing their carbon footprint over the past few years. However, there is no available data on Scope 3 emissions, which could provide a more comprehensive view of their overall impact. Despite these reductions, FNA has not publicly committed to specific reduction targets or initiatives, such as those outlined by the Science Based Targets initiative (SBTi). The absence of documented reduction targets suggests that while the company is making strides in emissions reduction, there may be opportunities for more structured climate commitments in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 540,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 4,338,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
FNA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
